NgenIRS is a four year partnership (2016-2019), led by IVCC and funded by Unitaid, that includes the US President’s Malaria Initiative, the Global Fund, Abt Associates and PATH.
The market shaping intervention project has $65.1 million funding and works in close collaboration with leading insecticide manufacturers, national malaria programmes and other stakeholders to increase the use of 3rd Generation Indoor Residual Spraying (3GIRS) products. This is done by supporting insecticide resistance and management strategies throughout Africa.
Project Aims
NgenIRS is establishing a sustainable, competitive and growing market for effective 3GIRS products at affordable prices.
We are making the most effective, long lasting insecticides available to malaria programmes and implementation partners to support insecticide resistance management strategies.
To achieve this we are addressing key barriers to Access through market shaping interventions:
Funding partner
Industry partners
NgenIRS - the evidence (2020)
Due to the NgenIRS project the downward trend in IRS use was reversed and the resulting expansion of use has resulted in significant public health impact, savings in commodity costs and new evidence showing the cost-effectiveness of 3GIRS.
NgenIRS evidence
Below are the project overview and evidence slide decks (in English and French) from the four-year project.
NgenIRS - behind the Project
IVCC’s Next Generation Indoor Residual Spraying (IRS) project is making a major difference in Africa. This video explains the strategy behind the project.